Skip to content

Zavation VCF-1015-2-E-BXX

by Zavation

Zavation VCF-1015-2-E-BXX is a balloon kyphoplasty kit (FDA Class II) made by Zavation, cleared under FDA 510(k) K141419 on 12 Sep 2014 and listed in FDA GUDID since 7 Nov 2018 (UDI-DI 00842166126978), active as of 22 Oct 2026. 36 FDA recalls are linked to it.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

36 closed

Documents

510(k) K141419

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00842166126978 UDI-DI Date7 Nov 2018ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK141419 Date12 Sep 2014DecidedStatusActive

Official records

From the FDA record

Device description
ZVplasty System Assembly
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied sterile; sterilise before use (Ethylene Oxide)

From the GUDID record (AccessGUDID), as read on 22 Oct 2026, as the labeller entered it.

Across registries

2 registries list this device

  • FDA 510(k) K141419 decided 12 Sep 2014 Active
  • FDA GUDID UDI-DI 00842166126978 listed 7 Nov 2018 Listed

Recalls

36 recalls · FDA

  • 36 recalls, same reason

    • Terminated Z-1740-2021 FDA Class II initiated 25 Mar 2021
    • Terminated Z-1739-2021 FDA Class II initiated 25 Mar 2021
    • Terminated Z-1748-2021 FDA Class II initiated 25 Mar 2021
    • Terminated Z-1722-2021 FDA Class II initiated 25 Mar 2021
    • Terminated Z-1734-2021 FDA Class II initiated 25 Mar 2021
    • Terminated Z-1709-2021 FDA Class II initiated 25 Mar 2021
    • Terminated Z-1732-2021 FDA Class II initiated 25 Mar 2021
    • Terminated Z-1729-2021 FDA Class II initiated 25 Mar 2021
    • Terminated Z-1724-2021 FDA Class II initiated 25 Mar 2021
    • Terminated Z-1704-2021 FDA Class II initiated 25 Mar 2021
    • Terminated Z-1733-2021 FDA Class II initiated 25 Mar 2021
    • Terminated Z-1712-2021 FDA Class II initiated 25 Mar 2021
    • Terminated Z-1746-2021 FDA Class II initiated 25 Mar 2021
    • Terminated Z-1700-2021 FDA Class II initiated 25 Mar 2021
    • Terminated Z-1728-2021 FDA Class II initiated 25 Mar 2021
    • Terminated Z-1737-2021 FDA Class II initiated 25 Mar 2021
    • Terminated Z-1725-2021 FDA Class II initiated 25 Mar 2021
    • Terminated Z-1726-2021 FDA Class II initiated 25 Mar 2021
    • Terminated Z-1705-2021 FDA Class II initiated 25 Mar 2021
    • Terminated Z-1738-2021 FDA Class II initiated 25 Mar 2021
    • Terminated Z-1741-2021 FDA Class II initiated 25 Mar 2021
    • Terminated Z-1735-2021 FDA Class II initiated 25 Mar 2021
    • Terminated Z-1723-2021 FDA Class II initiated 25 Mar 2021
    • Terminated Z-1708-2021 FDA Class II initiated 25 Mar 2021
    • Terminated Z-1747-2021 FDA Class II initiated 25 Mar 2021
    • Terminated Z-1721-2021 FDA Class II initiated 25 Mar 2021
    • Terminated Z-1736-2021 FDA Class II initiated 25 Mar 2021
    • Terminated Z-1711-2021 FDA Class II initiated 25 Mar 2021
    • Terminated Z-1707-2021 FDA Class II initiated 25 Mar 2021
    • Terminated Z-1706-2021 FDA Class II initiated 25 Mar 2021
    • Terminated Z-1710-2021 FDA Class II initiated 25 Mar 2021
    • Terminated Z-1703-2021 FDA Class II initiated 25 Mar 2021
    • Terminated Z-1702-2021 FDA Class II initiated 25 Mar 2021
    • Terminated Z-1742-2021 FDA Class II initiated 25 Mar 2021
    • Terminated Z-1743-2021 FDA Class II initiated 25 Mar 2021
    • Terminated Z-1713-2021 FDA Class II initiated 25 Mar 2021

    Products distributed as sterile may not have been adequately sterilized

Timeline

38 dated events

  1. Recall initiated FDA recalls Z-1736-2021
  2. Recall initiated FDA recalls Z-1711-2021
  3. Recall initiated FDA recalls Z-1707-2021
  4. Recall initiated FDA recalls Z-1706-2021
  5. Recall initiated FDA recalls Z-1710-2021
  6. Recall initiated FDA recalls Z-1703-2021
  7. Recall initiated FDA recalls Z-1702-2021
  8. Recall initiated FDA recalls Z-1742-2021
  9. Recall initiated FDA recalls Z-1743-2021
  10. Recall initiated FDA recalls Z-1713-2021

28 earlier events are in the sections above.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Zavation
Generic name
Balloon kyphoplasty kit
Model / reference
VCF-1015-2-E-BXX
Primary DI / UDI-DI
00842166126978
510(k) Number
FDA product code
NDN, HRX, GAA
GMDN term
Balloon kyphoplasty kit
Device class
Class II
Regulation number
888.3027, 888.1100, 878.4800
GUDID distribution status
In Commercial Distribution
Sterilisation method
Ethylene Oxide

Similar devices

Other devices filed under FDA product code NDN (Cement, Bone, Vertebroplasty).

Other devices from Zavation

See all devices from Zavation →

Properties

  • Supplied sterile
  • Sterilise before use
  • Single use
  • Prescription use
  • Lot / batch number
  • Expiration date
Other properties (9, all answered No)